BENZOIMIDAZOLVERBINDUNGEN UND IHRE VERWENDUNGEN

Patent europeic · EP2501697 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2501697
Numer da la dumonda
EP10831876
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
17-11-2010
Publitgà
26-09-2012
Concedì
23-10-2013
La protecziun finescha il pli tard
16-11-2030
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
C07D 413/06 (2006.01)
A61K 31/5377 (2006.01)
A61P 13/00 (2006.01)
A61P 25/04 (2006.01)
Prioritad
US 262263 P 18.11.2009
Dumonda PCT
PCT/SE2010/051269 17.11.2010
Publicaziun PCT
WO2011/062550 26.05.2011
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-12-2025

    Midada

    Published in Swissreg on 01.12.2025

  2. 01-12-2024

    Midada

    Published in Swissreg on 01.12.2024

  3. 23-05-2024

    Represchentant stritgà

    Owner
    Bellus Health Cough Inc., 275 Armand-Frappier Boulevard, Laval, Québec, H7V 4A7, Canada (allontanà)
    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex (allontanà)
    Inventor
    CANTIN, Louis-David, AstraZeneca R&D Montreal, 7171 Frederick-Banting, St. Laurent, Québec H4S 1Z9, Canada, LUO, Xuehong, AstraZeneca R&D Montreal, 7171 Frederic-Banting, St. Laurent, Québec H4S 1Z9, Canada, TOMASZEWSKI, Miroslaw, Jerzy, AstraZeneca R&D Montreal, 7171 Frederick-Banting, St. Laurent, Québec H4S 1Z9, Canada (allontanà)
    Register addresses

    Published in Swissreg on 23.05.2024

  4. 23-05-2024

    Transferì

    Published in Swissreg on 23.05.2024

  5. 23-05-2024

    Transferì

    Published in Swissreg on 23.05.2024

  6. 23-05-2024

    Transferì

    Published in Swissreg on 23.05.2024

  7. 23-05-2024

    Transferì

    Register addresses
    Owner
    GlaxoSmithKline Intellectual Property (No. 3) Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom
    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich
    Inventor
    CANTIN, Louis-David, AstraZeneca R&D Montreal, 7171 Frederick-Banting, St. Laurent, Québec H4S 1Z9, Canada, LUO, Xuehong, AstraZeneca R&D Montreal, 7171 Frederic-Banting, St. Laurent, Québec H4S 1Z9, Canada, TOMASZEWSKI, Miroslaw, Jerzy, AstraZeneca R&D Montreal, 7171 Frederick-Banting, St. Laurent, Québec H4S 1Z9, Canada

    Published in Swissreg on 23.05.2024

  8. 01-12-2023

    Midada

    Published in Swissreg on 01.12.2023

4 endataziuns pli veglias
  1. 06-12-2022

    Midada

    Published in Swissreg on 06.12.2022

  2. 17-06-2022

    Transferì

    Owner
    Neomed Institute, 7171 Rue Frederick-Banting,, Montréal QC H4S 1Z9, Canada → Bellus Health Cough Inc., 275 Armand-Frappier Boulevard, Laval, Québec, H7V 4A7, Canada

    Published in Swissreg on 17.06.2022

  3. 24-12-2013

    Represchentant inscrit

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 24.12.2013

  4. 23-10-2013

    Concedì

    Published in Swissreg on 23.10.2013

Partidas

Possessur

GlaxoSmithKline Intellectual Property (No.3) Limited

GlaxoSmithKline Intellectual Property (No. 3) Limited

GSK Medicines Research Centre Gunnels Wood Road, Stevenage, SG1 2NY, GB

Represchentant

Isler & Pedrazzini AG

Postfach, 8027 Zürich

Inventur

CANTIN, Louis-David

St. Laurent, Québec H4S 1Z9, CA

LUO, Xuehong

St. Laurent, Québec H4S 1Z9, CA

TOMASZEWSKI, Miroslaw, Jerzy

St. Laurent, Québec H4S 1Z9, CA

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.